Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine hydrochloride + povidone-iodine is a topical combination pharmaceutical product that pairs a local anesthetic with a broad-spectrum antiseptic, typically for use on skin or mucosal surfaces during minor procedures, wound care, or other settings where both pain reduction and infection control are desired. Lidocaine hydrochloride blocks voltage-gated sodium channels in peripheral nerve membranes to inhibit initiation and conduction of nerve impulses, producing local anesthesia. Povidone-iodine is an iodophor that gradually releases free iodine, which exerts rapid microbicidal activity through oxidation and iodination of microbial proteins, nucleotides, and membrane components against bacteria, fungi, viruses, and some protozoa. This combination is generally used as a locally acting symptomatic and anti-infective preparation rather than a systemically acting therapy, and specific commercial presentations, developers, manufacturers, indications, and dosage forms vary by market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine hydrochloride + povidone-iodine.